Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases

Area of Science:

• Cardiovascular Science
• Molecular Biology
• Biomarker Discovery

Background:

• Micro-RNAs (miRNAs) are crucial in cardiovascular development and disease.
• Cardiac-specific circulating miRNAs (c-miRNAs) show potential as diagnostic and therapeutic biomarkers for cardiovascular diseases (CVDs).
• c-miRNAs possess ideal biomarker characteristics, including stability, tissue specificity, and ease of detection.

Purpose of the Study:

• To review pre-analytical and analytical factors influencing c-miRNA quantification.
• To provide guidelines for enhancing the accuracy of diagnostic tests for cardiac c-miRNAs.
• To address discrepancies in current research on cardiac c-miRNA levels in circulation.

Main Methods:

• Literature review focusing on pre-analytical and analytical methodologies for c-miRNA detection.
• Analysis of factors impacting miRNA quantification in serum and plasma.
• Synthesis of data to establish best practices for c-miRNA measurement.

Main Results:

• Contradictory findings exist regarding cardiac c-miRNA levels in circulation.
• Pre-analytical and analytical variables significantly affect c-miRNA quantification results.
• Standardization of detection methods is crucial for reliable biomarker development.

Conclusions:

• Standardizing the quantification of circulating cardiac miRNAs is essential for their clinical application.
• Addressing methodological inconsistencies will improve the reliability of c-miRNA-based CVD diagnostics.
• Further research with standardized protocols is needed to validate cardiac c-miRNAs as biomarkers.